Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Oct;38(10):2480–2482. doi: 10.1128/aac.38.10.2480

Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model.

S B Duffull 1, E J Begg 1, S T Chambers 1, M L Barclay 1
PMCID: PMC284768  PMID: 7840593

Abstract

A dynamic in vitro model was used to assess four different vancomycin dosing regimens against Staphylococcus aureus. These regimens achieved peak drug concentrations of 48 micrograms/ml (single dose) and 30 micrograms/ml (dosed every 12 h) and constant concentrations of 16 and 8 micrograms/ml. Analysis of the area under the bacterial concentration-time curve, area under the first moment of the bacterial concentration-time curve, and bacterial elimination rate constant showed no difference in the rate or extent of bacterial killing. The optimal dosing method may be that which achieves the lowest area under the curve while concentrations are maintained above the MBC.

Full text

PDF
2480

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman B. H., Vannier A. M., Eudy E. B. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother. 1992 Aug;36(8):1766–1769. doi: 10.1128/aac.36.8.1766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arrieta A. C., Stutman H. R., Akaniro J. C., Vargas O. M. In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputum. Diagn Microbiol Infect Dis. 1992 Mar-Apr;15(3):247–251. doi: 10.1016/0732-8893(92)90120-i. [DOI] [PubMed] [Google Scholar]
  3. Barclay M. L., Begg E. J., Chambers S. T. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob Agents Chemother. 1992 Sep;36(9):1951–1957. doi: 10.1128/aac.36.9.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Begg E. J., Peddie B. A., Chambers S. T., Boswell D. R. Comparison of gentamicin dosing regimens using an in-vitro model. J Antimicrob Chemother. 1992 Apr;29(4):427–433. doi: 10.1093/jac/29.4.427. [DOI] [PubMed] [Google Scholar]
  5. Chambers S. T., Peddie B. A., Robson R. A., Begg E. J., Boswell D. R. Antimicrobial effects of lomefloxacin in vitro. J Antimicrob Chemother. 1991 Apr;27(4):481–489. doi: 10.1093/jac/27.4.481. [DOI] [PubMed] [Google Scholar]
  6. Craig W. A., Ebert S. C. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother. 1992 Dec;36(12):2577–2583. doi: 10.1128/aac.36.12.2577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duffull S. B., Chambers S. T., Begg E. J. How vancomycin is used in Australasia--a survey. Aust N Z J Med. 1993 Dec;23(6):662–666. doi: 10.1111/j.1445-5994.1993.tb04723.x. [DOI] [PubMed] [Google Scholar]
  8. Fitzsimmons W. E., Postelnick M. J., Tortorice P. V. Survey of vancomycin monitoring guidelines in Illinois hospitals. Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):598–600. doi: 10.1177/106002808802200719. [DOI] [PubMed] [Google Scholar]
  9. GERACI J. E., HEILMAN F. R., NICHOLS D. R., WELLMAN W. E. Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report. Proc Staff Meet Mayo Clin. 1958 Apr 2;33(7):172–181. [PubMed] [Google Scholar]
  10. Garrison M. W., Vance-Bryan K., Larson T. A., Toscano J. P., Rotschafer J. C. Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 1990 Oct;34(10):1925–1931. doi: 10.1128/aac.34.10.1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Geraci J. E. Vancomycin. Mayo Clin Proc. 1977 Oct;52(10):631–634. [PubMed] [Google Scholar]
  12. Greenberg R. N., Benes C. A. Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus. J Infect Dis. 1990 May;161(5):1036–1037. doi: 10.1093/infdis/161.5.1036. [DOI] [PubMed] [Google Scholar]
  13. Levine D. P., Fromm B. S., Reddy B. R. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991 Nov 1;115(9):674–680. doi: 10.7326/0003-4819-115-9-674. [DOI] [PubMed] [Google Scholar]
  14. Masur H., Francioli P., Ruddy M., Murray H. W. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clin Nephrol. 1983 Aug;20(2):85–88. [PubMed] [Google Scholar]
  15. Sorrell T. C., Packham D. R., Shanker S., Foldes M., Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):344–350. doi: 10.7326/0003-4819-97-3-344. [DOI] [PubMed] [Google Scholar]
  16. Van der Auwera P., Klastersky J. Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin. Antimicrob Agents Chemother. 1986 Dec;30(6):892–895. doi: 10.1128/aac.30.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Van der Auwera P., Klastersky J. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously. J Antimicrob Chemother. 1987 May;19(5):623–635. doi: 10.1093/jac/19.5.623. [DOI] [PubMed] [Google Scholar]
  18. Viladrich P. F., Gudiol F., Liñares J., Pallarés R., Sabaté I., Rufí G., Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991 Dec;35(12):2467–2472. doi: 10.1128/aac.35.12.2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilhelm M. P. Vancomycin. Mayo Clin Proc. 1991 Nov;66(11):1165–1170. doi: 10.1016/s0025-6196(12)65799-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES